scholarly journals Evaluation of Gianturco Coils for Closure of Large (≥3.5 mm) Patent Ductus Arteriosus 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco.

1997 ◽  
Vol 30 (7) ◽  
pp. 1856-1862 ◽  
Author(s):  
Carl Y. Owada ◽  
David F. Teitel ◽  
Phillip Moore
Keyword(s):  
Patent Ductus Arteriosus ◽  
San Francisco ◽  
Guest Editor ◽  
Ductus Arteriosus ◽  
University Of California ◽  
Editorial Decisions ◽  
The University ◽  
Selection Of ◽  
Patent Ductus ◽  
Gianturco Coils

The Silent Patent Ductus Arteriosus

PEDIATRICS ◽  
1983 ◽  
Vol 72 (4) ◽  
pp. 581-582
Author(s):  
R. CURTIS ELLISON ◽  
GEORGE J. PECKHAM ◽  
PETER LANG ◽  
NORMAN S. TALNER ◽  
TRUDY S. LERER ◽  
...  
Keyword(s):  
Patent Ductus Arteriosus ◽  
Distress Syndrome ◽  
Ductus Arteriosus ◽  
High Specificity ◽  
University Of California ◽  
Toxic Drug ◽  
Prime Concern ◽  
The University ◽  
Work Done ◽  
Patent Ductus

In Reply.— We appreciate the comments of Kashani, Swensson and Merritt. We are cognizant of the pioneering work done through the years at the University of California at San Diego in relation to the management of respiratory distress syndrome (RDS). The multicenter trial1 established diagnostic criteria for patent ductus arteriosus (PDA) in 1978. In view of the unknown toxicity of indomethacin at that time, high specificity rather than maximum sensitivity was of prime concern. We wanted to enroll in our trial only those infants in whom the degree of ductal shunting was leading to sufficient cardiopulmonary compromise to cause a threat to the infant and to warrant the use of a potentially toxic drug or surgery.

Sign in / Sign up

Export Citation Format

Share Document